Distinct properties of cell-type-specific and shared transcription factor binding sites

Molecular Cell

Volumn 52, Issue 1, 2013, Pages 25-36

  Gertz, Jason ^a   Savic, Daniel ^a   Varley, Katherine E ^a   Partridge, E Christopher ^a   Safi, Alexias ^b   Jain, Preti ^a   Cooper, Gregory M ^a   Reddy, Timothy E ^b,c   Crawford, Gregory E ^b,c   Myers, Richard M ^a  

^a HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV4; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SPECIFICITY; CELL TYPE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENOME; HUMAN; MOUSE; NONHUMAN;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CONSERVED SEQUENCE; DNA METHYLATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; RNA INTERFERENCE; THERMODYNAMICS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84885376679     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.08.037     Document Type: Article

References (44)

1. Abe Y., Ijichi N., Ikeda K., Kayano H., Horie-Inoue K., Takeda S., Inoue S. Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells. Cancer Sci. 2012, 103:806-812.
2. Boyle A.P., Davis S., Shulha H.P., Meltzer P., Margulies E.H., Weng Z., Furey T.S., Crawford G.E. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008, 132:311-322.
3. Butt A.J., Caldon C.E., McNeil C.M., Swarbrick A., Musgrove E.A., Sutherland R.L. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv. Exp. Med. Biol. 2008, 630:189-205.
4. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
5. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., et al. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
6. Chen Y., Chen L., Li J.Y., Mukaida N., Wang Q., Yang C., Yin W.J., Zeng X.H., Jin W., Shao Z.M. ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. Cancer Biol. Ther. 2011, 11:497-511.
7. Cooper G.M., Stone E.A., Asimenos G., Green E.D., Batzoglou S., Sidow A. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005, 15:901-913. NISC Comparative Sequencing Program.
8. Davydov E.V., Goode D.L., Sirota M., Cooper G.M., Sidow A., Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 2010, 6:e1001025. 10.1371/journal.pcbi.1001025.
9. A user's guide to the encyclopedia ofDNA elements (ENCODE). PLoS Biol. 2011, 9:e1001046. ENCODE Project Consortium. 10.1371/journal.pbio.1001046.
10. Gertz J., Cohen B.A. Environment-specific combinatorial cis-regulation in synthetic promoters. Mol. Syst. Biol. 2009, 5:244.
11. Gertz J., Siggia E.D., Cohen B.A. Analysis of combinatorial cis-regulation in synthetic and genomic promoters. Nature 2009, 457:215-218.
12. Gertz J., Varley K.E., Reddy T.E., Bowling K.M., Pauli F., Parker S.L., Kucera K.S., Willard H.F., Myers R.M. Analysis of DNA methylation in a three-generation family reveals widespread genetic influence onepigenetic regulation. PLoS Genet. 2011, 7:e1002228. 10.1371/journal.pgen.1002228.
13. Gertz J., Reddy T.E., Varley K.E., Garabedian M.J., Myers R.M. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012, 22:2153-2162.
14. Guertin M.J., Lis J.T. Chromatin landscape dictates HSF binding to target DNA elements. PLoS Genet. 2010, 6:e1001114. 10.1371/journal.pgen.1001114.
15. He H.H., Meyer C.A., Chen M.W., Jordan V.C., Brown M., Liu X.S. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 2012, 22:1015-1025.
16. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
17. Heldring N., Isaacs G.D., Diehl A.G., Sun M., Cheung E., Ranish J.A., Kraus W.L. Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol. Endocrinol. 2011, 25:564-574.
18. Hertz G.Z., Stormo G.D. Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics 1999, 15:563-577.
19. Hewitt S.C., Li L., Grimm S.A., Chen Y., Liu L., Li Y., Bushel P.R., Fargo D., Korach K.S. Research resource: whole-genome estrogen receptor alpha binding in mouse uterine tissue revealed by ChIP-seq. Mol. Endocrinol. 2012, 26:887-898.
20. Hurtado A., Holmes K.A., Ross-Innes C.S., Schmidt D., Carroll J.S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 2011, 43:27-33.
21. John S., Sabo P.J., Thurman R.E., Sung M.H., Biddie S.C., Johnson T.A., Hager G.L., Stamatoyannopoulos J.A. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 2011, 43:264-268.
22. Joseph R., Orlov Y.L., Huss M., Sun W., Kong S.L., Ukil L., Pan Y.F., Li G., Lim M., Thomsen J.S., et al. Integrative model of genomic factors fordetermining binding site selection by estrogen receptor-α. Mol. Syst. Biol. 2010, 6:456.
23. Kang J.G., Hamiche A., Wu C. GAL4 directs nucleosome sliding induced by NURF. EMBO J. 2002, 21:1406-1413.
24. Kong S.L., Li G., Loh S.L., Sung W.K., Liu E.T. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol. 2011, 7:526.
25. Krum S.A., Miranda-Carboni G.A., Lupien M., Eeckhoute J., Carroll J.S., Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Mol. Endocrinol. 2008, 22:2393-2406.
26. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J.Steroid Biochem. Mol. Biol. 2000, 74:311-317.
27. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
28. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
29. Meissner A., Mikkelsen T.S., Gu H., Wernig M., Hanna J., Sivachenko A., Zhang X., Bernstein B.E., Nusbaum C., Jaffe D.B., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454:766-770.
30. O'Lone R., Frith M.C., Karlsson E.K., Hansen U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 2004, 18:1859-1875.
31. Pennacchio L.A., Ahituv N., Moses A.M., Prabhakar S., Nobrega M.A., Shoukry M., Minovitsky S., Dubchak I., Holt A., Lewis K.D., et al. Invivo enhancer analysis of human conserved non-coding sequences. Nature 2006, 444:499-502.
32. Reddy T.E., Pauli F., Sprouse R.O., Neff N.F., Newberry K.M., Garabedian M.J., Myers R.M. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009, 19:2163-2171.
33. Ross-Innes C.S., Stark R., Teschendorff A.E., Holmes K.A., Ali H.R., Dunning M.J., Brown G.D., Gojis O., Ellis I.O., Green A.R., et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393.
34. Savic D., Gertz J., Jain P., Cooper G.M., Myers R.M. Mapping genome-wide transcription factor binding sites in frozen tissues. Epigenetics Chromatin 2013, 6. Published online September 16, 2013. 10.1186/1756-8935-6-30.
35. Shea M.A., Ackers G.K. The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. J.Mol. Biol. 1985, 181:211-230.
36. Simpson N.E., Gertz J., Imberg K., Myers R.M., Garabedian M.J. Research resource: enhanced genome-wide occupancy of estrogenreceptor alpha by the cochaperone p23 in breast cancer cells. Mol. Endocrinol. 2012, 26:194-202.
37. Song L., Crawford G.E. DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb. Protoc. 2010, pdb.prot5384. 10.1101/pdb.prot5384.
38. Stadler M.B., Murr R., Burger L., Ivanek R., Lienert F., Schöler A., van Nimwegen E., Wirbelauer C., Oakeley E.J., Gaidatzis D., et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011, 480:490-495.
39. Stender J.D., Kim K., Charn T.H., Komm B., Chang K.C., Kraus W.L., Benner C., Glass C.K., Katzenellenbogen B.S. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol. Cell. Biol. 2010, 30:3943-3955.
40. Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., et al. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 2013, 23:555-567.
41. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28:1418-1428.
42. Wiench M., John S., Baek S., Johnson T.A., Sung M.H., Escobar T., Simmons C.A., Pearce K.H., Biddie S.C., Sabo P.J., et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J. 2011, 30:3028-3039.
43. Wu W., Cheng Y., Keller C.A., Ernst J., Kumar S.A., Mishra T., Morrissey C., Dorman C.M., Chen K.B., Drautz D., et al. Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res. 2011, 21:1659-1671.
44. Yashwanth R., Rama S., Anbalagan M., Rao A.J. Role of estrogen in regulation of cellular differentiation: a study using human placental andrat Leydig cells. Mol. Cell. Endocrinol. 2006, 246:114-120.